Purine Analogs in Lymphoproliferative Disorders
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 11 (sup2) , 153-159
- https://doi.org/10.3109/10428199309064276
Abstract
(1993). Purine Analogs in Lymphoproliferative Disorders. Leukemia & Lymphoma: Vol. 11, No. sup2, pp. 153-159. doi: 10.3109/10428199309064276Keywords
This publication has 71 references indexed in Scilit:
- Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.Proceedings of the National Academy of Sciences, 1992
- A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.Journal of Clinical Oncology, 1991
- Fludarabine phosphate for the treatment of low grade lymphoid malignancyBritish Journal of Cancer, 1991
- Treatment of advanced chronic lymphocytic leukemia by fludarabineAnnals of Hematology, 1991
- Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.Journal of Clinical Oncology, 1991
- 2-Chlorodeoxyadenosine Chemotherapy Triggers Programmed Cell Death in Normal and Malignant LymphocytesPublished by Springer Nature ,1991
- 2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1991
- Current Status of U.S. Clinical Trials in Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1991
- Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working groupAmerican Journal of Hematology, 1988
- Low-dose deoxycoformycin in lymphoid malignancy.Journal of Clinical Oncology, 1985